Sales & Marketing From graduate to chairman: My 30 years in pharma In today’s world, working at the same company for 30 years is increasingly rare. Yet, that’s exactly what I’ve done.
News FDA clears Viridian's Tepezza rival for thyroid eye disease Viridian has fired a shot across Amgen's bows with the FDA approval of Tepezza rival Lumvoa in thyroid eye disease, a $2bn market.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
